Investigator & Patient Access

PRA's Investigator & Patient Access is a leader in the worldwide recruitment of:

• "Best in class" investigators
• Well-established Key Opinion Leaders (KOLs)
• High performing investigative sites
• Preferred vendors

Our access to established networks facilitates rapid subject enrollment with the highest standards of data quality and scientific integrity. These networks underpin PRA's successful delivery of global clinical trial projects.

PRA's global investigator database houses continually updated data for over 45,000 investigators across multiple therapeutic areas. The database is a valuable resource for site selection and feasibility assessment. It includes details about:

• Site capabilities
• Experience with international clinical trial participation
• Performance metrics

As PRA continues to recruit an increasing number of clinical trial participants from Asia, Latin America and Eastern Europe, we are establishing healthy and robust relationships with upcoming investigative sites to prepare the "next generation" of best-in-class investigators. A key advantage for our clients is access to sites that are able to enroll relatively large numbers of subjects over short time periods without compromising data quality.

In addition to cultivating relationships with sites, PRA has formed strategic alliances with IntrinsiQ Research and the Geriatric Oncology Consortium to accurately predict patient enrollment for clinical trials in oncology. This expanded access to information translates into faster study start-up, increased patient accrual and a more productive development process for our client’s oncology studies.